News Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss Missing the primary endpoint in a phase 3 trial will not stop Pfizer from submitting Valneva-partnered Lyme disease vaccine for approval.
News Hope rises for vaccine against hookworm parasite Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.
News Meningitis outbreak in UK prompts call to widen vaccination A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.
News China clears its first drug for chronic hepatitis D Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.
News Vaccination fall costs UK its measles elimination status The UK has lost its measles elimination status, according to the WHO, due to a spike in cases in 2024 and a fall in vaccination coverage.
News GSK preps filings for chronic hepatitis B drug bepirovirsen GSK will file its chronic hepatitis B virus therapy bepirovirsen for approval in the first quarter, after it hit the mark in two phase 3 trials.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.